Unique ID issued by UMIN | UMIN000040798 |
---|---|
Receipt number | R000046586 |
Scientific Title | Patient awareness survey on adverse events of glaucoma medications |
Date of disclosure of the study information | 2020/06/17 |
Last modified on | 2022/04/07 13:04:15 |
Patient awareness survey on adverse events of glaucoma medications
Patient awareness survey on adverse events of glaucoma medications
Patient awareness survey on adverse events of glaucoma medications
Patient awareness survey on adverse events of glaucoma medications
Japan |
Glaucoma
Ophthalmology |
Others
NO
Patient treated with a single medication for glaucoma and ocular hypertension will be surveyed through a web based questionnaire to investigate the factors affecting adherence and the patients awareness of adverse events caused by therapeutic agents.
Others
Psychological impact of adverse events
Effects of adverse events on intention to continue instillation
Effects of adverse events on intention to continue treatment
Psychological impact of adverse events
Effects of adverse events on intention to continue instillation
Effects of adverse events on intention to continue treatment
Others,meta-analysis etc
20 | years-old | <= |
Not applicable |
Male and Female
Treatment with one glaucoma/ocular hypertension drug for at least 1 year at the time of participation in the study
Those have history of open surgery (including laser treatment) for glaucoma
Those attending psychiatric or psychosomatic department
Medical professinals (doctors, pharmacists, nurses, etc.)
Those engaged in the manufacturing of pharmaceuticals and medical producsts
Person engaged in drug marketing
Those engaged in information provision services, research services and advertising
500
1st name | Kiyotaka |
Middle name | |
Last name | Hori |
Santen Pharmaceutical Co., Ltd.
Japan Medical Affairs
5308552
4-20, Ofukacho, Kita-ku, Osaka
06-4802-9603
clinical@santen.co.jp
1st name | Kazunori |
Middle name | |
Last name | Santo |
Santen Pharmaceutical Co., Ltd.
Japan Medical Affairs
5308552
4-20, Ofukacho, Kita-ku, Osaka
06-4802-9603
clinical@santen.co.jp
Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd.
Profit organization
Japan Conference of Clinical Research
1-13-23 Minamiikebukuro, Toshima-ku, Tokyo
03-6868-7022
jccr-info@jccr.jp
NO
2020 | Year | 06 | Month | 17 | Day |
Refer to published paper
Published
Refer to published paper
500
It was found that PAP adverse events associated with glaucoma eye drop treatment may be as emotionally taxing for patients as adverse events directly felt physically. This was a web-based survey conducted without a physician, and it can be considered that the burden of patients who cannot speak their true feelings in front of a physician became apparent.
2022 | Year | 04 | Month | 05 | Day |
2021 | Year | 12 | Month | 27 | Day |
Refer to published paper
Refer to published paper
Refer to published paper
Refer to published paper
The datasets are not publicly available, but are available from the corresponding author on reasonable request.
The datasets are not publicly available, but are available from the corresponding author on reasonable request.
Completed
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 16 | Day |
2020 | Year | 05 | Month | 29 | Day |
2020 | Year | 07 | Month | 22 | Day |
Web questionnaire survey
2020 | Year | 06 | Month | 17 | Day |
2022 | Year | 04 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046586
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |